GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
GeneDx announced 27 accepted abstracts at the ASHG 2026 Annual Meeting, including three platform presentations, three rapid-fire poster talks, and a Reviewer's Choice poster. Research spans AI-driven genomic interpretation, exome/genome sequencing as standard of care — including a 100,000+ individual autism cohort — gene discovery, and GUARDIAN newborn screening findings across more than 19,000 newborns.
Key figures
- Guardian newborns
- 19000
- Accepted abstracts
- 27
- Diagnosed diseases
- 4800
- Research publications
- 1000
- Platform presentations
- 3
- Autism cohort individuals
- 100000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.